Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#6845
Rank
S$0.78 B
Marketcap
S$39.27
Share price
-0.78%
Change (1 day)
-7.93%
Change (1 year)

Avalon Pharma (Middle East Pharmaceutical) (4016.SR) - Total debt

Total debt on the balance sheet as of September 2025 : S$21.5 Million

According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's total debt is S$21.5 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Avalon Pharma (Middle East Pharmaceutical) - Total debt on balance sheet (from 2023 to 2025)

Total debt by year

Year Total debt Change
2024-12-31S$23.72 M8.5%
2023-12-31S$21.86 M